In the first half of 2024, many posts on X, formerly Twitter, from U.S. health care professionals discussing COPD therapies focused on ventilation support, medications and palliative care ...

The list price for Breztri is $626 a month, but those with private insurance typically pay $55 a month. Both COPD and asthma are common diseases that affect a person's breathing.

Dupixent becomes the first FDA-approved biologic drug for treating uncontrolled COPD, offering new hope for patients with this chronic respiratory condition.

Medical experts discuss optimal treatment strategies and current standards of care surrounding therapy for patients with COPD.

Join Drs Leah Witt and Amber Martirosov as they discuss inhaled medications for chronic obstructive pulmonary disease, overlooked nuances of inhaler technique and why understanding Medicare is a ...

Medically reviewed by Brian Bezack, DO Over-the-counter (OTC) inhalers are not approved for treating chronic obstructive pulmonary disease (COPD). Aside from the fact that they are ineffective for ...

Study results show that patients with chronic obstructive pulmonary disease (COPD) and comorbid asthma may have a greater risk of hospitalization from COVID-19 if they use bronchodilators or ...

Even as the number and type of medications to treat chronic obstructive pulmonary disease (COPD) expands, poor adherence with medication regimens remains a stubborn problem that undermines optimal ...